Cargando…
Prospective Development of Small Molecule Targets to Oncogenic Ras Proteins
Abnormal expression or mutations in Ras proteins has been found in up to 30% of cancer cell types, making them excellent protein models to probe structure-function relationships of cell-signaling processes that mediate cell transformtion. Yet, there has been very little development of therapies to h...
Autores principales: | Chandrashekar, Reena, Adams, Paul D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226270/ https://www.ncbi.nlm.nih.gov/pubmed/25392746 http://dx.doi.org/10.4236/ojbiphy.2013.34025 |
Ejemplares similares
-
Small molecule inhibitors of RAS proteins with oncogenic mutations
por: Orgován, Zoltán, et al.
Publicado: (2020) -
Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling
por: Dhawan, Neil S., et al.
Publicado: (2016) -
Bioinformatics of non small cell lung cancer and the ras proto-oncogene
por: Kashyap, Amita, et al.
Publicado: (2015) -
The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021) -
Structure, signaling and the drug discovery of the Ras oncogene protein
por: Han, Chang Woo, et al.
Publicado: (2017)